Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Azenta to Participate in the Jefferies Healthcare Conference
By: PR Newswire Association LLC. - 30 May 2023Back to overview list

BURLINGTON, Mass., May 30, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Jefferies Healthcare Conference in New York, NY, on Thursday, June 8, 2023, which includes a presentation beginning at 11:30 am ET. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.

About Azenta Life Sciences

Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally.

Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.

INVESTOR CONTACTS:

Sara Silverman

Head of Investor Relations & Corporate Communications

ir@azenta.com

Sherry Dinsmore

sherry.dinsmore@azenta.com

Azenta logo (PRNewsfoto/Azenta)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/azenta-to-participate-in-the-jefferies-healthcare-conference-301837570.html

SOURCE Azenta

Related companies:Azenta Life Sciences | Azenta US, Inc
Copyright 2023 PR Newswire Association LLC. Back to overview list
to the top ↑